Pharmaceuticals

Puma Earns A, Apple Takes Home D in EIRIS Sustainability Rankings

Puma Earns A, Apple Takes Home D in EIRIS Sustainability RankingsGerman sportswear manufacturer Puma tops EIRIS' Top 10 Global Sustainability Leaders list while Apple earns a D, in a ranking that sees UK and European ...

May 2, 2012

Johnson & Johnson Expands Green Product Range

Johnson & Johnson Expands Green Product RangeJohnson & Johnson now has 30 products in its Earthwards portfolio of environmentally conscious health care and pharmaceutical products. The company added 19 products to the ...

March 2, 2012

EL Pro Standards & Compliance Briefing: Climate Bonds, ISO 50001, Cradle to Cradle, Green Leaf

Standards & Compliance Briefing: Climate Bonds, ISO 50001, Cradle to Cradle, Green LeafThe Climate Bonds Initiative has released a prototype Climate Bond Standard - a screening tool for investors and governments to support investment in the ...

November 29, 2011

EL Pro Policy & Enforcement Briefing: Solar Loan Guarantees, Keystone XL Delays, Merck Penalty

Policy & Enforcement Briefing: Solar Loan Guarantees, Keystone XL Delays, Merck PenaltyThe Energy Department has finalized more than $1 billion in loan guarantees for two large-scale solar projects, just before the Sept. 30 deadline expires for the ...

September 30, 2011

All CVS Locations Now Offer Disposal of Unwanted Medication

All CVS Locations Now Offer Disposal of Unwanted MedicationCVS has announced that all 7,200 of its locations now offer the Sharps Compliance Corp.'s Environmental Return System, which provides customers with the ability to safely ...

August 17, 2011

Pfizer Discusses its Strategic Plant Restructuring & Energy Master Plan

Pfizer Discusses its Strategic Plant Restructuring & Energy Master Plan Michael Becker, Director, Engineering, Pfizer Manufacturing Germany GmbH talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during ...

April 11, 2011

EL Pro GlaxoSmithKline Sets Carbon Neutrality Goal for 2050

GlaxoSmithKline Sets Carbon Neutrality Goal for 2050GlaxoSmithKline has set a target to achieve carbon neutrality across its value chain by 2050, as part of a new environmental strategy launched ...

March 30, 2011

EPA to Evaluate 134 Chemicals for Endocrine Disruption

EPA to Evaluate 134 Chemicals for Endocrine DisruptionThe U.S. Environmental Protection Agency  has released a list of 134 chemicals that will be screened for their potential to disrupt the endocrine system. Endocrine ...

November 17, 2010

Energy-Efficient Measures Saves Pfizer $2.6M in 2009

Energy-Efficient Measures Saves Pfizer $2.6M in 2009Pfizer has saved an average of $1.4 million annually between 2004 and 2009 by installing energy-efficient light fixtures, timers and occupancy sensors at all ...

October 7, 2010

Johnson & Johnson Completes Largest Solar Panel Array in NJ

Johnson & Johnson Completes Largest Solar Panel Array in NJ Tomorrow, on the campus of Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Johnson & Johnson ...

September 22, 2010

Environmental Leader Introduces EL Insights – Data, Market Intelligence and Insights on Energy and Environmental Technology

Environmental Leader Introduces EL Insights – Data, Market Intelligence and Insights on Energy and Environmental Technology Environmental Leader LLC is pleased to announce its latest offering for decision-makers, EL Insights, a subscription-based information source delivering critical data and insights on ...

June 2, 2010

Suppliers Push Medical OEMs Toward Eco-Friendly Plastics

Suppliers Push Medical OEMs Toward Eco-Friendly PlasticsThe medical device industry has been slow to incorporate biodegradable, bio-based or recycled plastics in their designs primarily due to cost, regulatory concerns, minimal selection and ...

March 12, 2010

Novo Nordisk Cuts CO2 Emissions by 32%, Water Use by 20%

Novo Nordisk Cuts CO2 Emissions by 32%, Water Use by 20%Novo Nordisk exceeded long-term targets for reducing CO2 emissions, water consumption and total energy consumption, while increasing its workforce by 8 percent and sales by 12 ...

February 8, 2010

Bristol-Myers Squibb, Sanofi-Aventis Tops Pharmaceutical Sustainability Report

Bristol-Myers Squibb, Sanofi-Aventis Tops Pharmaceutical Sustainability ReportBristol-Myers Squibb and Sanofi-Aventis earned the two highest scores in the pharmaceutical sector for sustainability reporting, according to a report from the Roberts Environmental Center ...

December 15, 2009

EL Pro Lilly Meets Energy-Efficiency Goals Ahead of Schedule

Lilly Meets Energy-Efficiency Goals Ahead of ScheduleEli Lilly, a global pharmaceutical company, has reached its energy goal two years early, improving its energy intensity (energy used per dollar of sales) by ...

October 23, 2009

EL Pro Pfizer Exceeds Emissions Reduction Goals, Misses Clean Energy Target

Pfizer Exceeds Emissions Reduction Goals, Misses Clean Energy TargetPfizer has achieved three of its four public environmental goals to reduce emissions, according to the company's 2009 corporate responsibility report (PDF). The pharmaceutical company ...

October 7, 2009

EL Pro Merck Slashes Energy Demand by 25%, Water Use by 15%

Merck Slashes Energy Demand by 25%, Water Use by 15%Merck has achieved and exceeded its corporate goal to reduce energy demand by 25 percent from a 2004 baseline and its water use by 15 ...

October 2, 2009

Abbott to Launch 40 Sustainable Packaging Initiatives

Abbott to Launch 40 Sustainable Packaging Initiatives Abbott is in the process of launching more than 40 sustainable packaging initiatives across its nutrition, pharmaceutical and medical product businesses to help achieve its ...

September 17, 2009

Group Wants Pharma Firms to Take Back Unused Meds

Group Wants Pharma Firms to Take Back Unused MedsIn a move reminiscent of the push for electronics manufacturers to take responsibility for e-waste recycling, the National Association of Counties (NACo), the nation's ...

July 30, 2009

EL Pro In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High

In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate HighOn a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of ...

June 5, 2009